Causes of cataract progression in glaucoma patients (report 2)

Hypotensive drops that penetrate into the aqueous humor of the anterior chamber cause thinning, roughness, irregularities, and microcracks in the anterior lens capsule, followed by the formation of microfibrils and pseudomembranes. In a five-year follow-up of 2532 glaucoma patients, nuclear cataract progression due to prolonged use of hypotensive eye drops was identified in 592 cases (23.4%).Patients with glaucoma exhibit a lower oxygen consumption rate by the lens (2.27 femtomoles/min/cell vs. a normal value of 2.83 femtomoles/min/cell), reduced oxygen utilization for adenosine triphosphate (ATP) production (0.72 femtomoles/min/cell vs. a normal value of 0.932 femtomoles/min/cell), and decreased maximal respiratory capacity of lens cells (4.17 vs. 5.46 femtomoles/min/cell). These changes represent risk factors for cataract development.In uveal glaucoma, blood proteins and inflammatory cells accumulate in the aqueous humor, posterior synechiae form between the iris and the anterior lens capsule, and fibrinous exudate develops in the pupillary area. Patients with uveal glaucoma receive anti-inflammatory and hypotensive pharmacotherapy, as well as laser and surgical treatments, including drainage device implantation. These factors contribute to a 34% increase in the incidence and progression of cataracts in uveal glaucoma patients.

Authors

Institutions

Publication Details

Journal
National Journal glaucoma
Published
2025-03-26
DOI
https://doi.org/10.53432/2078-4104-2025-24-1-58-64
Citations
1
Primary Topic
Glaucoma and retinal disorders
Type
article
Field-Weighted Citation Impact
1.71
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Causes of cataract progression in glaucoma patients (report 2)

E. A. Ivachev
1 citations
National Journal glaucoma
Glaucoma and retinal disorders
1.71
article

Causes of cataract progression in glaucoma patients (report 2)

E. A. Ivachev
article en
1 citations

Abstract

Hypotensive drops that penetrate into the aqueous humor of the anterior chamber cause thinning, roughness, irregularities, and microcracks in the anterior lens capsule, followed by the formation of microfibrils and pseudomembranes. In a five-year follow-up of 2532 glaucoma patients, nuclear cataract progression due to prolonged use of hypotensive eye drops was identified in 592 cases (23.4%).Patients with glaucoma exhibit a lower oxygen consumption rate by the lens (2.27 femtomoles/min/cell vs. a normal value of 2.83 femtomoles/min/cell), reduced oxygen utilization for adenosine triphosphate (ATP) production (0.72 femtomoles/min/cell vs. a normal value of 0.932 femtomoles/min/cell), and decreased maximal respiratory capacity of lens cells (4.17 vs. 5.46 femtomoles/min/cell). These changes represent risk factors for cataract development.In uveal glaucoma, blood proteins and inflammatory cells accumulate in the aqueous humor, posterior synechiae form between the iris and the anterior lens capsule, and fibrinous exudate develops in the pupillary area. Patients with uveal glaucoma receive anti-inflammatory and hypotensive pharmacotherapy, as well as laser and surgical treatments, including drainage device implantation. These factors contribute to a 34% increase in the incidence and progression of cataracts in uveal glaucoma patients.

National Journal glaucomaVol. 24(1)
Penza State University (RU)
Openalex Percentile: Top 21%
Glaucoma and retinal disorders
1.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Causes of cataract progression in glaucoma patients (report 2) — E. A. Ivachev · National Journal glaucoma (2025) | TGRS Research Map | TGRS